NL1031626A1 - Compounds useful in therapy. - Google Patents
Compounds useful in therapy.Info
- Publication number
- NL1031626A1 NL1031626A1 NL1031626A NL1031626A NL1031626A1 NL 1031626 A1 NL1031626 A1 NL 1031626A1 NL 1031626 A NL1031626 A NL 1031626A NL 1031626 A NL1031626 A NL 1031626A NL 1031626 A1 NL1031626 A1 NL 1031626A1
- Authority
- NL
- Netherlands
- Prior art keywords
- therapy
- compounds useful
- compounds
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/28—Two oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67354405P | 2005-04-20 | 2005-04-20 | |
| US67354405 | 2005-04-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL1031626A1 true NL1031626A1 (en) | 2006-10-23 |
| NL1031626C2 NL1031626C2 (en) | 2007-03-19 |
Family
ID=35044974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL1031626A NL1031626C2 (en) | 2005-04-20 | 2006-04-19 | Compounds useful in therapy. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7482375B2 (en) |
| EP (1) | EP1874732A1 (en) |
| JP (1) | JP2008536910A (en) |
| AR (1) | AR053587A1 (en) |
| CA (1) | CA2604218A1 (en) |
| DO (1) | DOP2006000088A (en) |
| GT (1) | GT200600155A (en) |
| NL (1) | NL1031626C2 (en) |
| PE (1) | PE20061316A1 (en) |
| TW (1) | TW200716609A (en) |
| UY (1) | UY29486A1 (en) |
| WO (1) | WO2006111856A1 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100491282B1 (en) | 1996-07-24 | 2005-05-24 | 워너-램버트 캄파니 엘엘씨 | Isobutylgaba and Its Derivatives for the Treatment of Pain |
| WO2008019048A1 (en) * | 2006-08-04 | 2008-02-14 | Meditrina Pharmaceuticals | Use of aromatase inhibitors for thining the endometrium or treating menorrhagia |
| US20080096950A1 (en) * | 2006-10-19 | 2008-04-24 | Karl Richard Gibson | Compounds Useful In Therapy |
| PE20081803A1 (en) * | 2007-03-09 | 2008-12-11 | Wyeth Corp | SYNTHESIS AND CHARACTERIZATION OF THE POLYMORPHIC FORM II OF 4- (2- (4,4-DIMETHYL-2-OXOOXAZOLIDIN-3-IL) THIAZOL-4-IL) BENZONITRILE |
| WO2008135824A1 (en) * | 2007-05-02 | 2008-11-13 | Pfizer Limited | Oxyalkylpyrazole compounds useful in therapy |
| WO2009075838A2 (en) * | 2007-12-10 | 2009-06-18 | Meditrina Pharmaceuticals, Inc. | Treatment of menorrhagia with aromatase inhibitor |
| WO2009119880A1 (en) * | 2008-03-26 | 2009-10-01 | Takeda Pharmaceutical Company Limited | Substituted pyrazole derivatives and use thereof |
| SG176464A1 (en) | 2008-05-09 | 2011-12-29 | Agency Science Tech & Res | Diagnosis and treatment of kawasaki disease |
| CA2735931A1 (en) * | 2008-09-18 | 2010-03-25 | Pfizer Limited | Amide compounds useful in therapy |
| US20150272622A1 (en) | 2011-12-22 | 2015-10-01 | Previvo Genetics, Llc | Recovery and processing of human embryos formed in vivo |
| BR112014029131B1 (en) | 2012-05-31 | 2021-03-09 | Allergan Pharmaceuticals International Limited | mucoadhesive capsule |
| CA2888377C (en) | 2012-11-02 | 2021-02-02 | Repros Therapeutics Inc. | Methods and compositions for treating progesterone-dependent conditions |
| EP2929883A1 (en) | 2014-04-08 | 2015-10-14 | Institut Pasteur | Pyrazole derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors |
| WO2015171392A1 (en) * | 2014-05-06 | 2015-11-12 | E. I. Du Pont De Nemours And Company | Fungicidal pyrazoles |
| US10786461B2 (en) | 2014-11-17 | 2020-09-29 | Context Biopharma Inc. | Onapristone extended-release compositions and methods |
| BR112018005999A2 (en) | 2015-09-25 | 2019-01-08 | Context Biopharma Inc | methods for the production of onapristone intermediates |
| KR20180113988A (en) | 2015-12-15 | 2018-10-17 | 컨텍스트 바이오파마 인코포레이티드 | Amorphous Ona Pristone Composition and Method of Manufacturing the Same |
| US20180148471A1 (en) | 2016-11-30 | 2018-05-31 | Arno Therapeutics, Inc. | Methods for onapristone synthesis dehydration and deprotection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3621024C2 (en) * | 1986-06-20 | 1999-10-28 | Schering Ag | 11beta-phenylestradienes, their preparation and pharmaceutical preparations containing them |
| NZ529403A (en) | 2001-04-10 | 2005-06-24 | Pfizer | Pyrazole derivatives for treating HIV |
| US6933312B2 (en) * | 2002-10-07 | 2005-08-23 | Agouron Pharmaceuticals, Inc. | Pyrazole derivatives |
-
2006
- 2006-04-10 EP EP06744619A patent/EP1874732A1/en not_active Withdrawn
- 2006-04-10 WO PCT/IB2006/001096 patent/WO2006111856A1/en not_active Application Discontinuation
- 2006-04-10 CA CA002604218A patent/CA2604218A1/en not_active Abandoned
- 2006-04-10 JP JP2008507193A patent/JP2008536910A/en active Pending
- 2006-04-11 DO DO2006000088A patent/DOP2006000088A/en unknown
- 2006-04-18 US US11/408,286 patent/US7482375B2/en not_active Expired - Fee Related
- 2006-04-18 AR ARP060101529A patent/AR053587A1/en unknown
- 2006-04-19 UY UY29486A patent/UY29486A1/en not_active Application Discontinuation
- 2006-04-19 NL NL1031626A patent/NL1031626C2/en not_active IP Right Cessation
- 2006-04-19 PE PE2006000409A patent/PE20061316A1/en not_active Application Discontinuation
- 2006-04-19 GT GT200600155A patent/GT200600155A/en unknown
- 2006-04-19 TW TW095113963A patent/TW200716609A/en unknown
-
2008
- 2008-12-12 US US12/333,533 patent/US20090099209A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7482375B2 (en) | 2009-01-27 |
| UY29486A1 (en) | 2006-11-30 |
| EP1874732A1 (en) | 2008-01-09 |
| US20090099209A1 (en) | 2009-04-16 |
| JP2008536910A (en) | 2008-09-11 |
| AR053587A1 (en) | 2007-05-09 |
| DOP2006000088A (en) | 2006-10-31 |
| WO2006111856A1 (en) | 2006-10-26 |
| GT200600155A (en) | 2007-04-18 |
| CA2604218A1 (en) | 2006-10-26 |
| NL1031626C2 (en) | 2007-03-19 |
| PE20061316A1 (en) | 2007-01-13 |
| TW200716609A (en) | 2007-05-01 |
| US20060241125A1 (en) | 2006-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL1031626A1 (en) | Compounds useful in therapy. | |
| NO2019033I1 (en) | regorafenib | |
| NL1029015A1 (en) | Therapeutic compounds. | |
| NL2000299A1 (en) | Compounds that are useful in a treatment. | |
| ATE525088T1 (en) | COMBINATION THERAPY | |
| NL1028967A1 (en) | 4-Phenylamino-quinazolin-6-yl-amides. | |
| NO20051522D0 (en) | Kabelskjotbeskytter. | |
| NO20070251A (en) | Well treatment | |
| NO20070297A (en) | Well treatment | |
| NO20053210D0 (en) | Linneslakkompensator. | |
| DE502005011333D1 (en) | eccentric | |
| NO20052746D0 (en) | Avlopsenhet. | |
| NO20041374D0 (en) | Bolgekraftverk. | |
| NO20052482D0 (en) | Redningskokong. | |
| NO20040762L (en) | Stromskinne. | |
| ITMI20051746A1 (en) | I.S. MACHINE | |
| ES1058102Y (en) | THERAPEUTIC LENTILLA. | |
| NO20045614D0 (en) | booster | |
| ITVR20040025A1 (en) | BED STRUCTURE | |
| NL1028622A1 (en) | Stelwig. | |
| ES1058898Y (en) | MATTRESS. | |
| DE602005000531D1 (en) | forming die | |
| ES1058958Y (en) | PERFECTED MASTIL. | |
| NL1025196A1 (en) | Rake-Sieve-Fork. | |
| ITMO20050310A1 (en) | THE STIMULATING DERMOPEADER TABLET |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AD1A | A request for search or an international type search has been filed | ||
| RD2N | Patents in respect of which a decision has been taken or a report has been made (novelty report) |
Effective date: 20061116 |
|
| PD2B | A search report has been drawn up | ||
| VD1 | Lapsed due to non-payment of the annual fee |
Effective date: 20091101 |